Applied Therapeutics, Inc.
Applied Therapeutics, Inc.（APLT）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · APLT · 截至 2026年6月9日
活动摘要
买入笔数
0
P-Purchase only
卖出笔数
1
近12个月
买卖比
0.00
Buy/Sell (by trades)
整体情绪
Applied Therapeutics, Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月9日
APLT 季度内部人买卖趋势
APLT 内幕交易卖出 · APLT 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 9, 2026
活跃内部人
近12个月交易最活跃 · APLT CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
APLT 高管卖出股份 · APLT 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Feb 3, 2026 | Kanter Stacy J. Director | Other | 22,500 | $2K | Form 4 |
| Feb 3, 2026 | Kanter Stacy J. Director | Other | 42,500 | $4K | Form 4 |
| Dec 19, 2025 | Hooks Corwin Dale Chief Commercial Officer | Award | 312,500 | — | Form 4 |
| Feb 3, 2026 | Hooks Corwin Dale Chief Commercial Officer | Other | 862,500 | $76K | Form 4 |
| Feb 3, 2026 | Hooks Corwin Dale Chief Commercial Officer | Other | 5,753 | — | Form 4 |
| Dec 19, 2025 | Chinoporos Constantine See Remarks | Award | 437,500 | — | Form 4 |
| Feb 3, 2026 | Chinoporos Constantine See Remarks | Other | 1,000,000 | $88K | Form 4 |
| Feb 3, 2026 | Chinoporos Constantine See Remarks | Other | 57,111 | — | Form 4 |
| Feb 3, 2026 | SKYLER JAY S Director | Other | 22,500 | $2K | Form 4 |
| Feb 3, 2026 | SKYLER JAY S Director | Other | 42,500 | $4K | Form 4 |
| Dec 19, 2025 | Funtleyder Leslie D. CFO · Director | Award | 1,187,500 | — | Form 4 |
| Feb 3, 2026 | Funtleyder Leslie D. CFO · Director | Other | 2,375,000 | $209K | Form 4 |
| Feb 3, 2026 | Funtleyder Leslie D. CFO · Director | Other | 152,959 | — | Form 4 |
| Dec 19, 2025 | Bailey Evan Prescott Chief Medical Officer | Award | 437,500 | — | Form 4 |
| Feb 3, 2026 | Bailey Evan Prescott Chief Medical Officer | Other | 1,235,915 | $109K | Form 4 |
| Feb 3, 2026 | Bailey Evan Prescott Chief Medical Officer | Other | 60,901 | — | Form 4 |
| Feb 3, 2026 | Lerner Teena Director | Other | 22,500 | $2K | Form 4 |
| Feb 3, 2026 | Lerner Teena Director | Other | 82,922 | $7K | Form 4 |
| Jan 1, 2026 | Funtleyder Leslie D. CFO · Director | Award | 150,000 | — | Form 4 |
| Dec 16, 2025 | Kanter Stacy J. Director | Sale | 43,000 | $5K | Form 4 |
| Oct 1, 2025 | Funtleyder Leslie D. CFO · Director | Award | 150,000 | — | Form 4 |
| Jul 1, 2025 | Funtleyder Leslie D. CFO · Director | Award | 150,000 | — | Form 4 |
| Jun 9, 2025 | Funtleyder Leslie D. CFO · Director | Award | 150,000 | — | Form 4 |
| Jun 15, 2025 | Bailey Evan Prescott Chief Medical Officer | Award | 300,000 | — | Form 4 |
| Mar 24, 2025 | Hooks Corwin Dale Chief Commercial Officer | Award | 250,000 | — | Form 4 |
Bailey Evan Prescott
Chief Medical Officer
日期
Feb 3
股数
1,235,915
均价
$0.09
总金额
$109K
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 APLT 内幕交易
APLT 内幕交易
Applied Therapeutics, Inc.（APLT）内幕交易数据来源于公司内部人（包括Funtleyder Leslie D. (CFO · Director), Bailey Evan Prescott (Chief Medical Officer), Kanter Stacy J. (Director)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。APLT内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Applied Therapeutics, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
APLT 内幕交易 · 5个问题Applied Therapeutics, Inc.（APLT）的内部人包括高管和董事，如Funtleyder Leslie D. (CFO · Director), Bailey Evan Prescott (Chief Medical Officer), Kanter Stacy J. (Director)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026